CytoDyn Inc. 8-K

What Happened

• CytoDyn Inc. (CYDY) filed a Form 8-K (April 30, 2026) to disclose an investor call and webcast scheduled for April 30, 2026 at 1:00 p.m. Pacific Time to provide a corporate and clinical update. The company referenced a press release dated April 23, 2026 with access instructions available on its website under Newsroom.

Key Details

• Investor call and webcast date/time: April 30, 2026 at 1:00 p.m. PT.
• Presentation materials relating to the call were furnished with the 8-K as Exhibit 99.1 (Presentation Slides dated April 30, 2026) and will be posted on the company website under Investor Update Calls.
• The company stated all information in the presentation speaks as of the date thereof and it does not assume an obligation to update the information, except as required by law.
• The Form 8-K was signed by Tyler Blok, Chief Legal Officer, on April 30, 2026.

Why It Matters

• This filing alerts investors that CytoDyn will provide an updated view of its corporate status and clinical programs; the live call and furnished slides give investors direct access to management commentary and recent clinical information.
• The 8-K does not report earnings, financial results, management changes, or other material transactions—it's a disclosure of an investor event and related presentation materials. Investors wanting the latest program details should review the posted presentation slides and the April 23 press release referenced in the filing.